Given the predicted functions of EG635895, EG635895 inhibitors can interfere with its kinase activity, disrupting the protein's role in signal transduction and phosphorylation processes. These inhibitors generally work by binding to the ATP-binding site of the kinase or by altering the conformation of the kinase domain, thus inhibiting the transfer of a phosphate group from ATP to the protein substrates. This inhibition can prevent the protein from fulfilling its role in phosphorylation events that are critical for various cellular processes, including cell cycle progression, apoptosis, and response to extracellular signals.
In conclusion, the inhibition of serine/threonine kinases can significantly impact cellular signaling pathways. The compounds listed above represent a broad spectrum of kinase inhibitors that can modulate kinase activity, affecting the phosphorylation state of downstream targets and thereby altering cell signaling cascades. These effects are achieved through the direct inhibition of kinase enzymatic activity, prevention of substrate binding, or destabilization of active kinase conformations. While the exact specificity and efficacy of these inhibitors on EG635895 would require empirical validation, they provide a starting point for understanding how the predicted kinase activity of EG635895 could be modulated by small molecule inhibitors.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent, non-selective inhibitor of protein kinases, including serine/threonine kinases. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A selective inhibitor of protein kinase C, a family of serine/threonine kinases. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A selective inhibitor of p38 MAP kinase, which is a serine/threonine-specific protein kinase. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
An adenosine kinase inhibitor that can also inhibit other serine/threonine kinases at higher concentrations. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), which is involved in serine/threonine phosphorylation. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
A selective inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII). | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An inhibitor of mTOR, a serine/threonine kinase involved in signaling pathways for cell growth and proliferation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A selective inhibitor of PI3K, which can affect downstream serine/threonine kinases like AKT. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of MEK, which acts upstream of the ERK serine/threonine kinases. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $163.00 $352.00 | 12 | |
An inhibitor of mTOR kinase, impacting the mTORC1 and mTORC2 complexes involved in serine/threonine kinase activity. | ||||||